Tilray Brands Inc

TLRY

Equity

ISIN null / Valor 42386407

NASDAQ (2026-10-06)

USD 3.78+1.61%

Tilray Brands Inc
UMushroom community rating:

2.50 2 votes No rating yet

NegativeNeutralPositive

About company

Tilray Brands Inc. is a global pioneer in the research, cultivation, production, and distribution of cannabis and cannabinoids. The company prides itself on a scientific approach to product development, emphasizing active ingredients, standardized preparations, and consistent, measured dosing. Tilray's product portfolio is rigorously tested for potency and purity, ensuring high-quality offerings across various categories, including medicinal and recreational cannabis. Under the leadership of CEO Irwin D. Simon, who has over 30 years of experience in building consumer packaged goods companies, Tilray has positioned itself as a leader in the global cannabis market. Simon's previous success in transforming Aphria Inc. into a profitable entity and his foundational role at The Hain Celestial Group highlight his capability to steer Tilray towards significant growth and market share. The company's operational excellence spans from cultivation to shipping, with a focus on precision, professionalism, and care at every stage of the process, aiming to deliver unparalleled products to its patients and consumers.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-76.1%1Y

-81.7%3Y

-96.5%5Y

Performance

97.1%1Y

92.1%3Y

89.8%5Y

Volatility

515 M

Market cap (USD)

3,633,188

Daily traded volume (Shares)

1.415 / 1.33

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

2.50

2 votes

Performance:

2.00

Innovation:

3.00

Society:

2.50

Nature:

2.50

Robin Roten

Switzerland, 04 Dec 2022

Tej Ram Kumpakha

Switzerland, 25 Mar 2022

Though the company is not successful yet to achieve the positive net profit; the share price is likely to increase mainly due the House Rules Committee voting on legalizing Cannabis.

EQUITIES OF THE SAME SECTOR

IQVIA Holdings Inc